After a 10-year transformation process from the integration of Telstar into the azbil Group, the management of the company at the highest-level will be transferred to two internal executives.
Read moreBeyond the Pill es un término holístico centrada en el paciente donde la salud y bienestar de una persona va más allá de simplemente tomar una píldora o medicamento y engloba la tecnología de la...
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today reported financial results for the hal...
Read moreInvestigadores del IBMCP-CSIC-UPV han colaborado en la secuenciación del genoma de Nicotiana benthamiana, que podría contribuir al desarrollo de nuevos productos terapéuticos
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreTelstar has taken control of 100% of its subsidiary in Mexico after signing a purchase execution contract with the company Bicor Technologies, to date a minority holding partner with 49% of the compan...
Read moreThe company promotes the development of digitization solutions in GMP environments and process automation for the pharmaceutical industry
Read moreThe basque Biopharmaceutical company is positioned as the main national distributor of bioreagents thanka to its constant expansion of represented brands.
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreTwo collaborative projects with Public Research Centers with a global budget of 2.3 million euros focused on the discovery and validation of new biomarkers and epigenetic targets in the treatment of n...
Read moreThe company to promote new digitization solutions in GMP environments and process automation for the pharmaceutical industry
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the company presented an ...
Read more